V CompBrief BY VELARION

Independent Director · MADRIGAL PHARMACEUTICALS, INC. (MDGL)

Chair, Audit Committee

Daniel J. Brennan director compensation at Madrigal (FY2025): $613K

Fiscal year 2025 director compensation for Daniel J. Brennan at MADRIGAL PHARMACEUTICALS, INC.. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed April 28, 2026 (DEF 14A). Open the filing on EDGAR.

Free

Get Daniel J. Brennan’s full pay file as a PDF — free

More than this page: up to 10 years of Daniel’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Daniel J. Brennan and every company like it: Velarion Intel, free for 3 days, no card →

What they were paid

MADRIGAL PHARMACEUTICALS Director Compensation Table · the one fiscal year held
In US dollars, as MADRIGAL PHARMACEUTICALS reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$28,646$584,451$0$0$613,097

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: MADRIGAL PHARMACEUTICALS, INC. DEF 14A filed April 28, 2026, accession 0001308179-26-000352, and prior-year filings. Open the filing on EDGAR.

How this page was built: the MADRIGAL PHARMACEUTICALS, INC. filed document, accession 0001308179-26-000352. Every figure is read from that document and cited to the page and table it appears in. Filed April 28, 2026.

Get the MADRIGAL PHARMACEUTICALS Board Governance Report

$613,097 Daniel J. Brennan, FY2025 total director compensation

$500

The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.

Data as of April 28, 2026 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).

How this board is paid

company policy · FY2025

MADRIGAL PHARMACEUTICALS pays directors a $50,000 cash retainer and $400,000 in RSUs and stock options.

Committees

FY2025 · as the proxy prints them

Audit (Chair)

The rest of the MADRIGAL PHARMACEUTICALS board

FY2025 · as the company reported each
DirectorRoleFY2025 total
Jacqualyn A. Fouse, Ph.DIndependent Director$761,744
James M. DalyIndependent Director$477,022
Julian C. BakerChair of the Board$503,397
Paul A. Friedman, M.DDirector$469,147
Raymond Cheong, M.D., Ph.DIndependent Director$494,897
Richard S. Levy, M.DIndependent Director$494,897

The full MADRIGAL PHARMACEUTICALS compensation record

free company brief
MADRIGAL PHARMACEUTICALS, INC. (MDGL) — free Compensation Briefevery named executive and director, board pay, say-on-pay, the peer group

This page is one director within MADRIGAL PHARMACEUTICALS's record. The company brief lists every named executive and director, each linking to their own page.

Peer companies

named in the MADRIGAL PHARMACEUTICALS proxy · each links to its own free brief

Order MDGL

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Board Governance Report